Detalhe da pesquisa
1.
Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes.
Proc Natl Acad Sci U S A
; 117(38): 23835-23846, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900948
2.
Severe Acute Kidney Injury Following Stage 1 Norwood Palliation: Effect on Outcomes and Risk of Severe Acute Kidney Injury at Subsequent Surgical Stages.
Pediatr Crit Care Med
; 17(7): 615-23, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27099973
3.
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.
J Virol
; 86(12): 6416-26, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491471
4.
ADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells.
J Virol
; 85(23): 12216-26, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917951
5.
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.
J Virol
; 82(16): 8210-4, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18495779
6.
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.
J Acquir Immune Defic Syndr
; 55(4): 420-7, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20856130